Sale of Adora Fertility - update
Filed with ASX · · 1 page · English
Healius Limited (Healius) (ASX:HLS) notes the announcement by Virtus Health Limited (ASX:VRT) (Virtus) dated 21 September 2021, concerning the Australian Competition and Consumer Commission’s (ACCC’s) notification of a public review in relation to the sale of the Adora Fertility business. Healius supports Virtus working constructively with the ACCC to achieve a timely outcome. Healius confirms the
Story so far
Earlier from Healius
- VRT: Update on acqn of Adora Fertility and Day Hospitals
- Media Release FY 2021 Results
- Sale of Adora Fertility
- Imaging - rebrand as Lumus Imaging and purchase of Axis
- Macquarie conference and trading update
Later from Healius
- VRT: Virtus response to ACCC regarding proposed Adora acqn
- VRT: Update on response - ACCC regarding proposed acquisition
- Trading Update 1QFY22
- VRT: Update on ACCC Court application on proposed acquisition
- Acquisition of Agilex Biolabs
Follow Healius into a list and get an email when it puts out news.
Follow Healius